Studies carried out in animal models have demonstrated higher levels of interleukin 23 (IL-23) and interleukin 17 (IL-17) in patients with type 1 diabetes, and in addition, the interferon (IFN) produced by T cells appears to be implicated in the destruction of Langerhans cell islets. Here, IL17A is linked to type 1 diabetes mellitus.